Elk Creek Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Elk Creek Partners’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-73,936	Closed	-$4.61M	–	137
2019 Q1	$4.61M	Sell	73,936 -31,956	-30%	-$2.11M	0.33%	104
2018 Q4	$6.42M	Sell	105,892 -8,338	-7%	-$498K	0.53%	80
2018 Q3	$6.68M	Sell	114,230 -47,609	-29%	-$2.43M	0.36%	108
2018 Q2	$7.26M	Sell	161,839 -3,246	-2%	-$140K	0.4%	101
2018 Q1	$7.32M	Sell	165,085 -3,629	-2%	-$152K	0.43%	94
2017 Q4	$7.31M	Sell	168,714 -1,388	-0.8%	-$62.4K	0.43%	98
2017 Q3	$7.91M	Buy	170,102 +24,696	+17%	+$1.18M	0.5%	83
2017 Q2	$7.2M	Sell	145,406 -5,657	-4%	-$296K	0.47%	85
2017 Q1	$8.28M	Buy	151,063 +5,011	+3%	+$265K	0.51%	76
2016 Q4	$8.13M	Buy	146,052 +7,923	+6%	+$381K	0.55%	74
2016 Q3	$6.31M	Buy	138,129 +6,982	+5%	+$280K	0.42%	89
2016 Q2	$5.24M	Buy	131,147 +10,454	+9%	+$383K	0.37%	97
2016 Q1	$4.2M	Buy	120,693 +17,975	+17%	+$660K	0.31%	109
2015 Q4	$4.41M	Sell	102,718 -3,802	-4%	-$190K	0.31%	107
2015 Q3	$4.64M	Buy	106,520 +12,641	+13%	+$682K	0.37%	101
2015 Q2	$4.84M	Buy	93,879 +10,522	+13%	+$449K	0.43%	97
2015 Q1	$3.26M	Buy	83,357 +19,335	+30%	+$758K	0.34%	117
2014 Q4	$2.47M	Buy	+64,022	New	+$2.44M	0.32%	123

Other funds holding BSTC

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Elk Creek Partners's BSTC Position: Q2 2019 in Review

Elk Creek Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2019, closing a stake of 73,936 shares — an estimated $4.61M sold.

Elk Creek Partners first reported a position in BSTC in Q4 2014 and held it in 18 quarters. The position peaked at $8.28M in Q1 2017. 114 funds tracked by Wall St. Rank hold BSTC as of Q2 2019.

Elk Creek Partners reported no remaining BioSpecifics Technologies Corp. position as of Q2 2019 after selling out during the quarter.
Elk Creek Partners sold 73,936 BioSpecifics Technologies Corp. shares in Q2 2019, an estimated $4.61M.
Elk Creek Partners first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and held it in 18 quarters.
Elk Creek Partners's BioSpecifics Technologies Corp. position peaked at $8.28M in Q1 2017.
114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2019.

Based on Elk Creek Partners's 13F filing for Q2 2019, filed 9 Aug 2019.